8-K: Teladoc Health Q4/FY25: Net Loss Shrinks, Revenue Flat

Teladoc Health reported a significantly reduced full-year net loss and flat fourth-quarter revenue, with mixed segment performance.

Summary

• Fourth Quarter 2025 revenue was $642.3 million, flat year-over-year.
• Full Year 2025 revenue was $2,530.0 million, down 2% year-over-year.
• Fourth Quarter 2025 net loss was $25.1 million, or $0.14 per share, a 48% improvement year-over-year.
• Full Year 2025 net loss was $200.3 million, or $1.14 per share, an 80% improvement year-over-year.
• Fourth Quarter 2025 adjusted EBITDA increased 12% year-over-year to $83.8 million.
• Full Year 2025 adjusted EBITDA decreased 10% year-over-year to $281.1 million.
• Full Year 2025 operating cash flow was $294.4 million, flat year-over-year.
• Full Year 2025 free cash flow was $166.9 million, down 2% year-over-year.
• The company ended 2025 with $781.1 million in cash and cash equivalents.
• Integrated Care segment revenue increased 5% in Q4 2025 and 3% for Full Year 2025.
• BetterHelp segment revenue decreased 7% in Q4 2025 and 9% for Full Year 2025.
• U.S. Integrated Care Members grew 9% to 101.8 million as of December 31, 2025.
• BetterHelp Paying Users decreased 6% in Q4 2025 and 5% for Full Year 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report with significant improvements in net loss but concerning declines in overall revenue growth and profitability for the BetterHelp segment, alongside a cautious outlook for 2026.

Positives

• Net loss significantly improved by 48% in Q4 2025 to $25.1 million and by 80% for Full Year 2025 to $200.3 million.
• Fourth Quarter 2025 adjusted EBITDA increased 12% year-over-year to $83.8 million.
• Integrated Care segment revenue increased 5% in Q4 2025 to $409.1 million and 3% for Full Year 2025 to $1,579.6 million.
• Integrated Care segment adjusted EBITDA increased 23% in Q4 2025 to $65.3 million and 3% for Full Year 2025 to $239.2 million.
• U.S. Integrated Care Members increased by 9% to 101.8 million as of December 31, 2025.
• International revenue increased 19% in Q4 2025 to $125.0 million and 12% for Full Year 2025 to $458.2 million.
• Operating cash flow remained flat year-over-year at $294.4 million for Full Year 2025.
• Tax benefits of $20.1 million from a research and development tax credit study and $15.0 million related to current year acquisitions were recognized in Full Year 2025.

Negatives

• Full Year 2025 revenue decreased 2% year-over-year to $2,530.0 million.
• Full Year 2025 adjusted EBITDA decreased 10% year-over-year to $281.1 million.
• BetterHelp segment revenue decreased 7% in Q4 2025 to $233.2 million and 9% for Full Year 2025 to $950.4 million.
• BetterHelp segment adjusted EBITDA decreased 15% in Q4 2025 to $18.5 million and 46% for Full Year 2025 to $41.9 million.
• Access fees revenue decreased 4% in Q4 2025 and 6% for Full Year 2025.
• U.S. revenue decreased 3% in Q4 2025 and 4% for Full Year 2025.
• Average Monthly Revenue Per U.S. Integrated Care Member decreased 4% in Q4 2025 to $1.34 and 6% for Full Year 2025 to $1.29.
• BetterHelp Paying Users decreased 6% in Q4 2025 to 0.375 million and 5% for Full Year 2025 to 0.386 million.
• Non-cash goodwill impairment charges of $71.8 million were recorded for Full Year 2025 related to Integrated Care segment acquisitions.
• Free cash flow slightly decreased by 2% for Full Year 2025 to $166.9 million.
• The Full Year 2026 outlook projects flat to slightly negative revenue growth and a decrease in adjusted EBITDA compared to Full Year 2025 actuals.

Risks

• Changes in laws and regulations applicable to the business model.
• Changes in market conditions and receptivity to services and offerings, including the ability to effectively compete.
• Results of litigation or regulatory actions.
• The loss of one or more key clients or the loss of a significant number of members or BetterHelp paying users.
• Changes in valuations or useful lives of assets.
• Changes to abilities to recruit and retain qualified providers into the network.
• The impact of and risk related to impairment losses with respect to goodwill or other assets.
• The success of initiatives to improve efficiency and competitiveness.
• Imposed and threatened tariffs by the United States and its trading partners, and any resulting disruptions or inefficiencies in the supply chain.

Future Outlook

For the full year 2026, Teladoc Health expects revenue between $2,470 million and $2,587 million, adjusted EBITDA between $266 million and $308 million, net loss per share between ($1.10) and ($0.70), and free cash flow between $130 million and $170 million. U.S. Integrated Care Members are projected to be between 97 million and 100 million. Integrated Care revenue growth is anticipated between 0.40% and 3.90%, with an adjusted EBITDA margin of 15.10% 16.10%. BetterHelp revenue growth is expected to be between (7.00%) and (0.50%), with an adjusted EBITDA margin of 3.00% 4.60%. For the first quarter of 2026, revenue is expected between $598 million and $620 million, adjusted EBITDA between $50 million and $62 million, and net loss per share between ($0.45) and ($0.35).

Management Comments

• "We closed 2025 with a solid finish, delivering consolidated revenue and adjusted EBITDA above the midpoint of our guidance ranges for the fourth quarter."
• "I'm encouraged by the progress we made last year against each of our strategic priorities, as we strengthened our product portfolio, advanced innovation across Integrated Care and BetterHelp, and positioned the company to build on this momentum in 2026."
• "Our focus remains on disciplined execution and performance acceleration as we progress through the year, with a clear commitment to advancing care and delivering better outcomes."
• "Through continued product innovation and by leveraging advancements in our technology, we are strengthening our ability to meet the evolving needs of our clients and members to support sustainable growth over time."

Industry Context

StockSavvy.ai notes that Teladoc Health, as a global leader in virtual care, operates in a rapidly evolving market. The mixed performance across its Integrated Care and BetterHelp segments reflects broader industry trends where traditional telehealth services (Integrated Care) are seeing steady adoption, while direct-to-consumer mental health platforms (BetterHelp) face increased competition and market saturation, impacting growth and profitability. The company's focus on product innovation and technology advancements is crucial for maintaining its competitive edge and adapting to changing client and member needs in the digital health landscape.

Stakeholder Impact

• Shareholders: Mixed results with improved net loss but declining revenue growth and a cautious outlook may lead to uncertainty regarding future stock performance. Goodwill impairment charges could impact asset values.
• Clients (Health Plans, Employers, Providers, Health Systems): Continued product innovation and focus on better outcomes aim to meet evolving needs, potentially strengthening relationships and client retention.
• Members/Paying Users: Continued innovation and focus on care delivery are intended to support evolving needs and improve health outcomes, which could impact user satisfaction and retention.
• Employees: Restructuring costs related to severance and office space reductions indicate potential workforce adjustments and impact on employee morale.

Next Steps

• An earnings conference call and webcast will be held on Wednesday, February 25, 2026, at 5:00 p.m. E.T.
• The company's focus remains on disciplined execution and performance acceleration throughout 2026.
• Continued product innovation and leveraging advancements in technology are planned to meet evolving client and member needs and support sustainable growth.

Key Dates

Recommendation

While Teladoc Health showed significant improvement in reducing its net loss and the Integrated Care segment demonstrated growth, the overall revenue decline for the full year and the substantial drop in the BetterHelp segment's performance are concerning. The 2026 outlook suggests continued challenges with flat to slightly negative revenue growth and a further decrease in adjusted EBITDA. Given the mixed results, the competitive landscape in virtual care, and the cautious forward guidance, a "hold" recommendation is appropriate for investors to observe if the company can stabilize BetterHelp and accelerate overall growth in 2026.

Keywords

Teladoc Health, TDOC, virtual care, telehealth, financial results, Q4 2025, full year 2025, earnings, adjusted EBITDA, net loss, revenue, Integrated Care, BetterHelp, virtual therapy, chronic care management, digital health, healthcare technology